Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

3D ultrasound could predict chemo success in breast cancer

NCT ID NCT02834494

First seen Jan 06, 2026 · Last updated Jun 20, 2026 · Updated 31 times

Summary

This study tested whether a special 3D ultrasound technique called shear wave elastography can predict how well breast cancer responds to chemotherapy before surgery. Researchers measured tumor stiffness in 140 women with locally advanced breast cancer at several points during treatment. The goal was to see if changes in stiffness could accurately forecast the final tumor response, potentially reducing the need for biopsies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED BREAST CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Institut Curie Paris

    Paris, 75005, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

3D Shear Wave Elastography (ultrasound imaging technique)

What this could lead to

If successful, this imaging method could help doctors quickly see if chemotherapy is working, allowing them to adjust treatment earlier for better outcomes.

What could go wrong

This is a completed observational study, not a treatment trial. The technique may not be accurate enough to replace standard biopsy or may not work for all tumor types.

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.